Cardival Medical - About the company
Cardival Medical is an acquired company based in Santa Clara (United States), founded in 2002. It operates as a Developer of a device for vascular access management. Cardival Medical has raised $169M in funding from LKCM. The company has 126 active competitors, including 45 funded and 28 that have exited. Its top competitors include companies like TISSIUM, Vivasure Medical and Laminate Medical.
Company Details
Developer of a device for vascular access management. The company has two products Vascade is a fully integrated, extravascular, bioabsorbable femoral access closure system and CATALYST is designed to provide temporary hemostasis and enhance coagulation for patients.
- Website
- cardivamedical.com
- Registered Address
- Santa Clara, California
Key Metrics
Founded Year
2002
Location
Santa Clara, United States
Stage
Acquired
Total Funding
$169M in 14 rounds
Latest Funding Round
Ranked
9th among 126 active competitors
Employee Count
241 as on Mar 31, 2026
Exit Details
Acquired by Haemonetics (Jan 20, 2021)
Legal entities associated with Cardival Medical
Cardival Medical is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CARDIVA MEDICAL, INC. CIN: 300113686 , United States, Active | Dec 26, 999 | - | 133 (As on Dec 31, 2019) | - |
Cardival Medical's acquisition details
Cardival Medical got acquired by Haemonetics on Jan 20, 2021 at an acquisition amount of $*****.
Click here to take a look at Cardival Medical's acquisition in detail
Sign up to download Cardival Medical's company profile
Cardival Medical's funding and investors
Cardival Medical has raised a total funding of $169M over 14 rounds. Its latest funding round was a Series E round on Jul 14, 2020 for $*****. 4 investors participated in its latest round. Cardival Medical has 15 institutional investors.
Here is the list of recent funding rounds of Cardival Medical:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 14, 2020 | 4610841 | Series E | 9255829 | 5718949 | 3427506 | 5066409 |
Feb 20, 2018 | 4177766 | Conventional Debt | 5179325 | 2604595 | 6090204 | |
Feb 20, 2018 | 3738484 | Series D | 4764542 | 6317495 | 4101503 |
Access funding benchmarks and valuations. Sign up today!View details of Cardival Medical's funding rounds and investors
Cardival Medical's founders and board of directors
Founder? Claim ProfileCardival Medical's employee count trend
Cardival Medical has 241 employees as of Mar 26. Here is Cardival Medical's employee count trend over the years:
Uncover Cardival Medical's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cardival Medical's Competitors and alternates
Top competitors of Cardival Medical include TISSIUM, Vivasure Medical and Laminate Medical. Here is the list of Top 10 competitors of Cardival Medical, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of vascular sealant for open vascular surgery | $190M | 66/100 | ||
2nd |  Vivasure Medical 2009, Galway (Ireland), Acquired | Developer of polymer implants and delivery systems | $92.1M | 61/100 | |
3rd | Laminate Medical 2012, Rehovot (Israel), Series C | Device to prevent AV Fistula failure by promoting their maturation and patency | $20M | 52/100 | |
4th | EKOS Corporation 1995, Bothell (United States), Acquired | Developer of a device for thrombolysis to treat pulmonary embolism | $58.8M | 52/100 | |
5th | ivWatch 2010, Williamsburg (United States), Series E | Detecting Intravenous infiltration | $90.1M | 51/100 | |
6th | AccessClosure 2002, Mountain View (United States), Acquired | Vascular closure device | $18.7M | 50/100 | |
7th | Access Vascular 2015, Bedford (United States), Series C | Developer of hydrogel-based devices to improve venous access | $54.3M | 50/100 | |
8th | Semprus BioSciences 2006, Cambridge (United States), Acquired | Provider of bio-functional medical surfaces to interface between the body and implantable devices | $26M | 50/100 | |
9th | Cardival Medical 2002, Santa Clara (United States), Acquired | Developer of a device for vascular access management | $169M | 49/100 | |
10th |  Vantis Vascular 2022, San Jose (United States), Series C | Provider of a medical device for vascular interventions | $30M | 48/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Cardival Medical's competitors? Click here to see the top ones
Cardival Medical's Investments and acquisitions
Cardival Medical has made no investments or acquisitions yet.
Reports related to Cardival Medical
Here is the latest report on Cardival Medical's sector:
News related to Cardival Medical
Filter this list•
BioSig taps two regional directors to lead its commercial expansion across southeast and central regions of the USProactive Investors•Apr 15, 2021•BioSig, CardioFocus, Cardival Medical, Boston Scientific
•
•
Cardiva Medical Announces First Patients Enrolled in The AMBULATE Same Day Discharge Study Using VASCADE® MVPGlobeNewswire•Jul 16, 2020•Cardival Medical
•
Former Intersect ENT Finance Chief Joins Cardiva Medical BoardMedical Product Outsourcing•Feb 18, 2020•Cardival Medical, Novocure
•
Cardiva Medical Appoints Jeri Hilleman to the Company’s Board of DirectorsBusiness Wire•Jan 10, 2020•Cardival Medical, Novocure
•
Cardiva Medical Announces Publication of Data From the AMBULATE Pivotal Study in the Journal of the American College of Cardiology: Clinical ElectrophysiologyBusiness Wire•Oct 30, 2019•Cardival Medical
•
FDA Approves Cardiva Medical's VASCADE MVP Vascular Closure System for Multi-Site Vessel ClosureMedical Product Outsourcing•Feb 04, 2019•Cardival Medical
•
FDA approves Cardiva’s new bioabsorbable vessel closure systemFierce Biotech•Dec 27, 2018•Cardival Medical
•
Cardiva Medical Announces FDA Approval of the VASCADE MVP Vascular Closure System for Multi-Site Vessel Closure Following Electrophysiology ProceduresBusiness Wire•Dec 18, 2018•Cardival Medical
•
Global Arteriotomy Closure Devices Market Research Analysis 2018 -Abbott, St. Jude Medical, Cardinal Health and Arstasisthefuturetechnologies.com•Nov 30, 2018•Abbott, Arstasis, St. Jude Medical, Cardinal Health and 3 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Cardival Medical
Explore our recently published companies
- Greenplast - Bengaluru based, 2020 founded, Unfunded company
- Fine Pharma Pack - India based, 2023 founded, Unfunded company
- Sushil Pharma - Ichalkaranji based, Unfunded company
- Swarajya Stones - Navi Mumbai based, Unfunded company
- Fotostudio AB - Netherlands based, Unfunded company
- V-TAG Software - Hyderabad based, Unfunded company
